Adrian Rawcliffe shared GlaxoSmithKline’s motto – Do more feel better and live longer – and explained how having a global strategy is a new requirement for success for pharmaceutical companies. His most interesting comment was about how the company turned to the McLaren Group to develop a better data analysis strategy. McLaren wins a lot […]
Takeda announced positive late-stage results for its new type 2 diabetes drug, fasiglifam (TAK-875), the first GPR40 agonist to reach late-stage development. Fasiglifam has the potential to be a compelling therapeutic option and will likely be investigated for use in combination therapy, given its unique mechanism of action. The Japanese drug maker is in desperate […]
How Apella leverages technology to increase OR efficiency.
During the early 1990’s, many solo family practitioners got caught up in the growing trend of joining a larger group. Today, those larger groups are again looking to combine to take advantage of what size has to offer in the field of medicine. Here are a few things to look for when integrating medical practices. […]
In 2014, the health insurance tax will increase the already hefty cost of healthcare coverage for employers relying on insured products to cover their workforce. To offset this added burden, as well as other Affordable Care Act (ACA) challenges, a number of companies have switched to self-insuring their health benefits. Self-insurance offers an employer greater […]
Calculating the return on investment of expensive drugs and surgeries can mean good news for patients. A recent conversation among decision makers at big insurance companies also showed that payers aren’t the heartless bureaucrats they are often made out to be. Leaders from UnitedHealth Group, Blue Cross Blue Shield Minnesota and Aetna explained how they […]
DUBLIN (Reuters) – Irish drugmaker Elan Corporation has agreed a $1 billion royalties deal that could soothe concerns about its potentially risky acquisition strategy and fend off a takeover bid from Royalty Pharma. Elan, battling to keep its independence after rejecting Royalty’s $5.7 billion bid last month, is buying 21 percent of the royalties that […]
How Zelis hopes to solve the healthcare financial system for payers and providers.
Some advice is good enough to repeat and repeat and repeat. Marti Nyman is managing director of Altavail Partners, LLC, an innovation, strategy and business acceleration consultancy. He also writes at Think. Act. Grow. He recently spoke at a meet up of Healthcare.mn to share advice about building a new company. The advice is not […]
I’ve said repeatedly that any cloud/SaaS vendor that wants to be taken seriously in healthcare must be willing to sign a HIPAA Business Associate Agreement (BAA) and I was happy to hear that Box.com is now willing to do so. I’m quite pleased that we’re finally seeing some serious healthcare SaaS offerings from [...]
A new Silicon Valley Bank report on the medical device tax has more bright spots than you would expect. Executives from device companies seem to feel optimistic, even though they expect the tax to delay profitability.
I just left the healthcare industry for the second time and it’s sad the level of ignorance and superstition that exists around computers . . . and SQL especially. The entire industry treats computers like big electronic pieces of paper. They print things they can easily email, they manually enter in things they could easily […]
Richard Fu details the company's approach to nutrition therapy and strategy for patients using GLP-1s.
Career postings are like little gold mines for competitive intelligence. Recruiting departments of most firms are unaware how valuable job descriptions can be to their competitors. To entice the best candidates, all too often postings give away invaluable tidbits on the inside structure and workings of a company … who this job reports to, what […]
In addition to bringing the toothbrush into the 21st century, Beam Brush is changing the prototyping process for medical device startups. “We are one of the first consumer medical device companies to use 3D printers and one of the first companies to own the Replicator 2,” co-founder Alex Fromeyer said. Beam has used the 3D […]
Early stage med tech companies often have little time, money or resources to commit to marketing activities, especially when their exciting new technologies may be months or years away from commercialization. The whole concept of marketing can be downright daunting when you barely have a product. The absolute marketing fundamental, and where most companies start […]
On the stage at the 2013 Consumer Electronics Show, will.i.am’s Christian Louboutin loafers stood out like a neon light in a field of brown and gray business shoes. He wouldn’t fit in at Medtronic or Humana or Eli Lilly either, but that is exactly why he should be there. Will.i.am helps Intel figure out what […]
Big medtech companies have been criticized for their diminishing innovation record, especially from this blog. One of the few innovation strengths that large companies should exhibit is manufacturing. And, I’m not referring to advanced manufacturing in itself, but the synergy between manufacturing and R&D. In the mid-nineties, I had the pleasure to experience Cordis Corporation (pre- […]